
2.83MUSD
Type
Common Stock
Exchange
NASDAQ
Currency Code
USD
Currency Name
US Dollar
Country Name
USA
Country ISO
US
ISIN
GB00BNGF1L75
CUSIP
-
Sector
Healthcare
Industry
Biotechnology
Fiscal Year End
December
IPO date
-
Updated At
-
PE Ratio
-
PEG Ratio
-
Book Value
24.49
Dividend Share
-
Dividend Yield
-
Earnings Share
-3.31
Wall Street Target Price
35.05
EPS Estimate Current Year
-
EPS Estimate Next Year
-
EPS Estimate Current Quarter
0
EPS Estimate Next Quarter
0
Most Recent Quarter
-
Revenue TTM
83,000
Gross Profit TTM
-3,961,000
EBITDA
-8,593,000
Profit Margin
0.00%
Return On Assets TTM
-32.79%
Return On Equity TTM
-64.72%
Revenue Per Share TTM
0.435
Qtly Revenue Growth YOY
-64.10%
Diluted Eps TTM
-3.31
Qtly Earnings Growth YOY
0.00%
Trailing PE
0.00
Forward PE
0
Price Sales TTM
0.5761
Price Book MRQ
0.9478
Enterprise Value Revenue
4
Enterprise Value EBITDA
0
330.43
3.65%748.57
0.26%712.02
0.00%305.36
-4.62%299.00
-3.85%24.20
-2.46%153.08
-1.38%434.29
-1.03%95.56
-0.96%761.00
-0.17%